Shortage Watch Free FDA drug-shortage watch

← all medications

Pentostatin Injection

Brand names: Nipent

Category: Oncology

Unavailable 1

FDA status: Current · Last FDA update: Aug 27, 2026 · First posted: Aug 27, 2026 (in shortage 1 month) · 1 manufacturers, 1 listed presentations

As of Aug 27, 2026, the FDA lists Pentostatin Injection as currently in shortage. Of 1 manufacturer presentations, 1 Unavailable.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Pentostatin Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
Presentation & package NDCManufacturerAvailabilityFDA note
Nipent, Injection, 10 mg, single dose vial (NDC 0409-0801-01)
NDC 0409-0801-01		 Hospira, Inc., a Pfizer Company Unavailable Next delivery: Q2 2027; Estimated recovery: Q3 2027; Shortage per manufacturer: manufacturing delays

Related medications in shortage

Other Oncology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Pentostatin Injection (FDA data as of Aug 27, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Pentostatin Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Pentostatin Injection.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/pentostatin-injection.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).